In United States Publish
Post Time: 2025-07-24

Chris Shibutani, Goldman Sachs anlayst, joins 'Squawk on the Street' to discuss what gives the analyst the confidence Eli Lilly and Novo Nordisk can continue to perform, what happens to the anti-obesity industry in 2030, and how the market will evolve.

Goldman Sachs Raises Target On Eli Lilly: Here's Why For Country: United States. City: Abilene, Gainesville, Huntington Beach, Lafayette, Oxnard

Tag: #How You Can Help, #check these guys out, #read on, #check out this site, #visit site